|
KMID : 1022820210120020035
|
|
Journal of Multiple Sclerosis and Neuroimmunology
2021 Volume.12 No. 2 p.35 ~ p.38
|
|
|
Delayed Hepatitis B Reactivation after Repeated Rituximab Treatments for Neuromyelitis Optica Spectrum Disorder
|
|
Lee Hye-Sun
Sung Eui-Hyun
Sung Won-Jae
Kim Seung-Hyun
|
|
|
Abstract
|
|
|
|
Rituximab is a chimeric mouse human anti-CD20 monoclonal antibody that can reduce B cell numbers and antibody levels and has been prescribed for refractory neuromyelitis optica spectrum disorder (NMOSD). We report a case of delayed hepatitis B reactivation after repeated rituximab treatments with antibodies against aquaporin-4 in a seropositive NMOSD patient with chronic hepatitis B infection.
|
|
|
KEYWORD
|
|
|
Neuromyelitis optica, Hepatitis B, Rituximab
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|